Overcoming Clinical Challenges in Integrating Avutometinib/Defactinib Into Routine Practice for KRAS-Mutated Low-Grade Serous Ovarian Carcinoma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Clinical Focus in KRAS-Mutated Low-Grade Serous Ovarian Cancer: Integrating a Novel Dual MEK/FAK Inhibitor Into Practice

Content Format:

Text Module

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.75
KRAS-Mutated Low-Grade Serous Ovarian Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
A Newly Approved Targeted Combination Therapy for KRAS-Mutant Low-Grade Serous Ovarian Cancer

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--